Superior Planning, LLC’s Ascendis Pharma A/S ASND Stock Holding History

Superior Planning, LLC’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.2K	Buy	+36	New	+$9.12K	﹤0.01%	1005

Other funds holding ASND

Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Superior Planning, LLC's ASND Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Ascendis Pharma A/S (ASND) in Q3 2026: 36 shares worth $8.2K. The stake represents ﹤0.01% of the portfolio and ranks #1005 among its holdings.

200 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

Superior Planning, LLC held 36 shares of Ascendis Pharma A/S worth $8.2K as of Q3 2026.
Ascendis Pharma A/S was a new Superior Planning, LLC position in Q3 2026.
Ascendis Pharma A/S made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1005 holding.
200 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.